A long-running confirmatory trial of two of Sarepta Therapeutics’ Duchenne muscular dystrophy drugs has missed its main goal.

A value proposition is a statement or promise you make that attempts to position your brand as worthy of being noticed and purchased from. Basically, a value proposition helps your customer answer the ...

Start by conducting a soil test ( https://go.uvm.edu/soiltest) for any vegetable and berry gardens, plus additional, separate ...

Adam Hayes, Ph.D., CFA, is a financial writer with 15+ years Wall Street experience as a derivatives trader. Besides his extensive derivative trading expertise, Adam is an expert in economics and ...

A novel machine learning gene risk biomarker test successfully predicted patient response to semaglutide treatment after ...

Clonal hematopoiesis of indeterminate potential (CHIP) is a known risk factor for coronary artery disease, though its precise role in disease progression continues to emerge. This study leverages ...

Background Stroke after transcatheter aortic valve implantation (TAVI) is an infrequent but serious complication with ...

The pressure is on to deliver growth because that’s one way they can quiet criticism that their stock prices have shot too high in recent months.

Cypherpunk Technologies Inc., previously known as Leap Therapeutics, Inc. (Nasdaq:LPTX), a company developing novel therapies for patients ...

A 79-year-old man was admitted to a hospital in Guangzhou, China, with progressive dyspnea and edema. Echocardiography and ...

The future of AI will hinge on the dynamic between enablers – the cloud, software and semiconductor giants – and adopters – ...